UBS AM’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $890K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $328K | Sell |
|
|||||
|
2021
Q2 | $410K | Buy |
|
|||||
|
2021
Q1 | $229K | Sell |
|
|||||
|
2020
Q4 | $323K | Hold |
|
|||||
|
2020
Q3 | $328K | Buy |
|
|||||
|
2020
Q2 | $258K | Buy |
|
|||||
|
2020
Q1 | $210K | Sell |
|
|||||
|
2019
Q4 | $287K | Sell |
|
|||||
|
2019
Q3 | $273K | Buy |
|
|||||
|
2019
Q2 | $320K | Buy |
|
|||||
|
2019
Q1 | $264K | Buy |
|
|||||
|
2018
Q4 | $196K | Hold |
|
|||||
|
2018
Q3 | $241K | Buy |
|
|||||
|
2018
Q2 | $277K | Buy |
|